Epstein Secrets

ers <https://www.reuters.corn/article/us-usa-court/trump-supreme-court-gains-steam-as-romney-backs- election-year-senate-vote-idUSKCN26D I GU> (9/22, Sullivan) reports "Romney's decision left Democrats with few hopes of blocking Senate confirmation of the Republican president's third appointment to the hig

. Bloomberg <https://www.bloomberg.com/news/articles/2020-09-22/pfizer-s-covid-vaccine-trial-plan-may-beat- rivals-to-early-look?smd=premium> (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot wo

uture Justice Department arising" from his work as an unregistered foreign agent of Turkey in 2016, "his inconsistent statements under oath to Judge Sullivan and any potential perjury or false statements to [special counsel Robert] Mueller's team or to the grand juries it used." The CNN <https://www.cnn.

f it's approved." Bloomberg <https://www.bloomberg.com/news/articles/2020-11-30/modema-plans-to-seek-u-s-eu-clearance-for- covid-19-vaccine> (11/30, Langreth, 4.73M) reports the US "reached a deal worth as much as $1.5 billion for 100 million doses of the Modena shot in August," while the EU, Canada, and

Burton, Subscription Publication, 8.41M) also have reports. J&J Says It Should Have Enough Doses For More Than 20M By End Of March. The Hill (2/22, Sullivan, 5.69M) reports Johnson & Johnson said Monday that it "plans to have enough doses of its vaccine for more than 20 million Americans by the end of Ma

believes in science, not conspiracy theories." FDA Outlines Fast Path For New Vaccines, Booster Shots To Cover New Virus Variants. Bloomberg (2/22, Langreth, Cortez, 3.57M) reports, "Drugmakers won't have to perform massive trials for new vaccines or booster shots developed to combat worrisome new varian

uture Justice Department arising" from his work as an unregistered foreign agent of Turkey in 2016, "his inconsistent statements under oath to Judge Sullivan and any potential perjury or false statements to (special counsel Robert] Mueller's team or to the grand juries it used." The CNN (11/30, Polantz,

en done is we have been helping to position the vaccine in the warehouses where they can access it immediately if it's approved." Bloomberg (11/30, Langreth, 4.73M) reports the US "reached a deal worth as much as $1.5 billion for 100 million doses of the Moderna shot in August," while the EU, Canada, and

9/22, Swoyer, 492K), "Romney's support for moving the confirmation process forward so close to the Nov. 3 elections was a surprise." Reuters (9/22, Sullivan) reports "Romney's decision left Democrats with few hopes of blocking Senate confirmation of the Republican president's third appointment to the hig

Biden and Kamala Harris undermining the confidence of the American people." Pfizer's COVID Vaccine Trial On Track To Beat Rivals. Bloomberg (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot wo

uture Justice Department arising" from his work as an unregistered foreign agent of Turkey in 2016, "his inconsistent statements under oath to Judge Sullivan and any potential perjury or false statements to [special counsel Robert] Mueller's team or to the grand juries it used." The CNN (11/30, Polantz,

en done is we have been helping to position the vaccine in the warehouses where they can access it immediately if it's approved." Bloomberg (11/30, Langreth, 4.73M) reports the US "reached a deal worth as much as $1.5 billion for 100 million doses of the Moderna shot in August," while the EU, Canada, and

9/22, Swoyer, 492K), "Romney's support for moving the confirmation process forward so close to the Nov. 3 elections was a surprise." Reuters (9/22, Sullivan) reports "Romney's decision left Democrats with few hopes of blocking Senate confirmation of the Republican president's third appointment to the hig

Biden and Kamala Harris undermining the confidence of the American people." Pfizer's COVID Vaccine Trial On Track To Beat Rivals. Bloomberg (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot wo